Pergolide Mesylate 66104-23-2
Product Description
.cp_wz table {border-top: 1px solid #ccc;border-left:1px solid #ccc; } .cp_wz table td{border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;} .cp_wz table th {border-right: 1px solid #ccc;border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;}
Pergolide mesylate (trade name Permax) is an ergoline-based dopamine
receptor agonist used in some countries for the treatment of Parkinson's
disease. Pergolide mesylate functions as an agonist at the dopamine D2,
D1 and serotonin 5-HT1A, 5-HT1B, 5-HT2A, 5-HT2B, and 5-HT2C receptors. It may possess agonist activity at other dopamine receptor subtypes as well, similar to cabergoline.
Pergolide mesylate decreases plasma prolactin concentrations. The weak agonist activity of pergolide at D1 receptors somewhat alters
its clinical and side effect profile in the treatment of Parkinson's
disease. The drug is in decreasing use, as it is reported to be
associated with a form of heart disease called cardiac fibrosis. The
use of pergolide or cabergoline is associated with a significantly
increased risk of newly diagnosed cardiac-valve regurgitation.
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.
Chemical Information
Molarity Calculator
Dilution Calculator
Molecular Weight Calculator
Contact us if you need more details on 66104-23-2. We are ready to answer your questions on packaging, logistics, certification or any Other aspects about 66104-23-2 Pergolide Mesylate、Pergolide Mesylate 66104-23-2. If these products fail to match your need, please contact us and we would like to provide relevant information.
Pergolide mesylate (trade name Permax) is an ergoline-based dopamine
receptor agonist used in some countries for the treatment of Parkinson's
disease. Pergolide mesylate functions as an agonist at the dopamine D2,
D1 and serotonin 5-HT1A, 5-HT1B, 5-HT2A, 5-HT2B, and 5-HT2C receptors. It may possess agonist activity at other dopamine receptor subtypes as well, similar to cabergoline.
Pergolide mesylate decreases plasma prolactin concentrations. The weak agonist activity of pergolide at D1 receptors somewhat alters
its clinical and side effect profile in the treatment of Parkinson's
disease. The drug is in decreasing use, as it is reported to be
associated with a form of heart disease called cardiac fibrosis. The
use of pergolide or cabergoline is associated with a significantly
increased risk of newly diagnosed cardiac-valve regurgitation.
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species | Baboon | Dog | Monkey | Rabbit | Guinea pig | Rat | Hamster | Mouse |
Weight (kg) | 12 | 10 | 3 | 1.8 | 0.4 | 0.15 | 0.08 | 0.02 |
Body Surface Area (m2) | 0.6 | 0.5 | 0.24 | 0.15 | 0.05 | 0.025 | 0.02 | 0.007 |
Km factor | 20 | 20 | 12 | 12 | 8 | 6 | 5 | 3 |
Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
Animal A Km |
For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.
Rat dose (mg/kg) = mouse dose (22.4 mg/kg) × | mouse Km(3) | = 11.2 mg/kg |
rat Km(6) |
Chemical Information
Molecular Weight (MW) | 410.59 |
---|---|
Formula | C19H26N2S.CH4O3S |
CAS No. | 66104-23-2 |
Storage | 3 years -20℃Powder |
---|---|
6 months-80℃in solvent (DMSO, water, etc.) | |
Synonyms | LY127809 |
Solubility (25°C) * | In vitro | DMSO | 10 mg/mL (24.35 mM) |
---|---|---|---|
Water | 82 mg/mL (199.71 mM) | ||
Ethanol | <1 mg/mL ( | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Chemical Name | Ergoline, 8-[(methylthio)methyl]-6-propyl-, (8β)-, monomethanesulfonate (9CI) |
---|
Molarity Calculator
Dilution Calculator
Molecular Weight Calculator
Contact us if you need more details on 66104-23-2. We are ready to answer your questions on packaging, logistics, certification or any Other aspects about 66104-23-2 Pergolide Mesylate、Pergolide Mesylate 66104-23-2. If these products fail to match your need, please contact us and we would like to provide relevant information.
Product Categories : Neuronal Signaling > Dopamine Receptor Inhibitor
Other Products
Hot Products
Astragaloside AChlortetracycline HCl 64-72-2Paclitaxel 33069-62-4Dexamethasone Acetate 1177-87-3Dinaciclib (SCH727965) 779353-01-4CHIR-124 405168-58-3Ro3280 1062243-51-9TAME 901-47-3CCG-1423 285986-88-110058-F4 403811-55-2Dabigatran (BIBR 953) 211914-51-1H 89 2HCl 130964-39-5T0901317 293754-55-9Aprepitant 170729-80-3Turofexorate Isopropyl (XL335) 629664-81-9BMS-378806 357263-13-9